留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

基于细胞骨架的分子可视化成像技术评估结直肠癌转移

张东辉 廖清 严萍萍 赵亮

张东辉, 廖清, 严萍萍, 赵亮. 基于细胞骨架的分子可视化成像技术评估结直肠癌转移[J]. 分子影像学杂志, 2023, 46(1): 37-42. doi: 10.12122/j.issn.1674-4500.2023.01.07
引用本文: 张东辉, 廖清, 严萍萍, 赵亮. 基于细胞骨架的分子可视化成像技术评估结直肠癌转移[J]. 分子影像学杂志, 2023, 46(1): 37-42. doi: 10.12122/j.issn.1674-4500.2023.01.07
ZHANG Donghui, LIAO Qing, YAN Pingping, ZHAO Liang. Evaluation of colorectal cancer metastasis by molecular visualization imaging based on cytoskeleton[J]. Journal of Molecular Imaging, 2023, 46(1): 37-42. doi: 10.12122/j.issn.1674-4500.2023.01.07
Citation: ZHANG Donghui, LIAO Qing, YAN Pingping, ZHAO Liang. Evaluation of colorectal cancer metastasis by molecular visualization imaging based on cytoskeleton[J]. Journal of Molecular Imaging, 2023, 46(1): 37-42. doi: 10.12122/j.issn.1674-4500.2023.01.07

基于细胞骨架的分子可视化成像技术评估结直肠癌转移

doi: 10.12122/j.issn.1674-4500.2023.01.07
详细信息
    作者简介:

    张东辉,主管技师,E-mail: 18819129896@163.com

    通讯作者:

    赵亮,博士,主任医师,E-mail: liangsmu@foxmail.com

Evaluation of colorectal cancer metastasis by molecular visualization imaging based on cytoskeleton

  • 摘要:   目的  基于细胞骨架的分子可视化成像技术阐明LIM蛋白1(LIMK1)诱导结直肠转移的具体机制。  方法  构建过表达LIMK1处理组细胞SW480/HA-LIMK1及空白对照组细胞SW480/HA,鬼笔环肽染色法分子可视化成像技术检测过表达LIMK1对SW480细胞骨架蛋白的影响;沉默LIMK1、ACTN4和MYH9,鬼笔环肽染色法分子可视化成像技术检测其对细胞骨架的影响,Transwell迁移实验检测沉默ACTN4和MYH9对LIMK1介导的细胞迁移的影响。  结果  在SW480细胞系中,过表达LIMK1后细胞骨架蛋白F-肌动蛋白染色明显增强,而使用siRNA沉默ACTIN4或MYH9的表达后,这种增加可以被恢复。此外,在SW480细胞系中沉默这两种蛋白,可以抑制LIMK1介导的恶性迁移运动表型(P<0.05)。  结论  LIMK1可能通过与ACTIN4或MYH9相互作用来调节细胞骨架,促进结直肠癌细胞的迁移和侵袭。

     

  • 图  1  过表达LIMK1的效率验证

    A: 蛋白印迹法检测LIMK在SW480细胞中的表达; B: 免疫荧光实验验证LIMK1过表达(scale bar=20 μm).

    Figure  1.  Efficiency verification of overexpressed LIMK1.

    图  2  免疫荧光检测SW480细胞骨架蛋白F-actin

    Figure  2.  Immunofluorescence detection of SW480 cytoskeleton protein F-actin (Phalloidin, cyclopeptide, red) (scale bar=20 μm).

    图  3  蛋白印迹法检测LIMK1、ACTIN4、MYH9在SW480细胞中的表达(A)及相对蛋白表达量统计图(B

    Figure  3.  Detection of LIMK1, ACTIN4 and MYH expression in SW480 cells by Western blot (A) and statistical histogram of relative protein expression (B).

    图  4  鬼笔环肽(Phalloidin,红色荧光)染色检测SW480细胞骨架改变

    Figure  4.  Detection of SW480 cytoskeleton by Phalloidin staining(red) (scale bar=20 μm).

    图  5  Transwell迁移实验检测SW480细胞的迁移运动能力

    **P<0.05.

    Figure  5.  Detection of migration ability of SW480 cells by Transwell migration assay (scale bar=50 μm).

    表  1  用于转染的siRNA序列

    Table  1.   siRNA sequences for transfection

    基因名称 Sense 5' to 3' Antisense 5' to 3'
    LIMK1 CGCACCAGUACUAUGAGAATT UUCUCAUAGUACUGGUGCGTT
    ACTN4 GACCAGAGCUGAUUGAGUATT UACUCAAUCAGCUCUGGUCTT
    MYH9 GGAGCGGAACACUGACCAGTT CUGGUCAGUGUUCCGCUCCTT
    阴性对照 UUCUCCGAACGUGUCACGUTT ACGUGACACGUUCGGAGAATT
    下载: 导出CSV
  • [1] Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CAA Cancer J Clin, 2020, 70(3): 145-64. doi: 10.3322/caac.21601
    [2] Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis[J]. Br J Pharmacol, 2014, 171(24): 5507-23. doi: 10.1111/bph.12704
    [3] Mori T, Okano I, Mizuno K, et al. Comparison of tissue distribution of two novel serine/threonine kinase genes containing the LIM motif (LIMK-1 and LIMK-2) in the developing rat[J]. Mol Brain Res, 1997, 45(2): 247-54. doi: 10.1016/S0169-328X(96)00257-4
    [4] Nagata K, Ohashi K, Yang N, et al. The N-terminal LIM domain negatively regulates the kinase activity of LIM-kinase 1[J]. Biochem J, 1999, 343(Pt 1): 99-105.
    [5] Ohashi K, Hosoya T, Takahashi K, et al. A Drosophila homolog of LIM-kinase phosphorylates cofilin and induces actin cytoskeletal reorganization[J]. Biochem Biophys Res Commun, 2000, 276(3): 1178-85. doi: 10.1006/bbrc.2000.3599
    [6] Nishimura Y, Yoshioka K, Bernard O, et al. A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells[J]. Histochem Cell Biol, 2006, 126(5): 627-38. doi: 10.1007/s00418-006-0198-x
    [7] Ishaq M, Lin BR, Bosche M, et al. LIM kinase 1-dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes[J]. BMC Mol Biol, 2011, 12: 41. doi: 10.1186/1471-2199-12-41
    [8] Bagheri-Yarmand R, Mazumdar A, Sahin AA, et al. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system[J]. Int J Cancer, 2006, 118(11): 2703-10. doi: 10.1002/ijc.21650
    [9] Davila M, Frost AR, Grizzle WE, et al. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells[J]. J Biol Chem, 2003, 278(38): 36868-75. doi: 10.1074/jbc.M306196200
    [10] Liao Q, Li R, Zhou R, et al. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression[J]. Br J Cancer, 2017, 117(4): 563-71. doi: 10.1038/bjc.2017.193
    [11] Nunoue K, Ohashi K, Okano I, et al. LIMK-1 and LIMK-2, two members of a LIM motif-containing protein kinase family[J]. Oncogene, 1995, 11(4): 701-10.
    [12] Scott RW, Olson MF. LIM kinases: function, regulation and association with human disease[J]. J Mol Med, 2007, 85(6): 555-68. doi: 10.1007/s00109-007-0165-6
    [13] Honda K, Yamada T, Endo R, et al. Actinin-4, a novel actinbundling protein associated with cell motility and cancer invasion[J]. J Cell Biol, 1998, 140(6): 1383-93. doi: 10.1083/jcb.140.6.1383
    [14] Shao HS, Li SY, Watkins SC, et al. α-actinin-4 is required for amoeboid-type invasiveness of melanoma cells[J]. J Biol Chem, 2014, 289(47): 32717-28. doi: 10.1074/jbc.M114.579185
    [15] Honda K, Yamada T, Hayashida Y, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer[J]. Gastroenterology, 2005, 128(1): 51-62. doi: 10.1053/j.gastro.2004.10.004
    [16] Simons M, Wang M, McBride OW, et al. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes[J]. Circ Res, 1991, 69(2): 530-9. doi: 10.1161/01.RES.69.2.530
    [17] Katono K, Sato Y, Jiang SX, et al. Prognostic significance of MYH9 expression in resected non-small cell lung cancer[J]. PLoS One, 2015, 10(3): e0121460. doi: 10.1371/journal.pone.0121460
    [18] Zhou W, Fan MY, Wei YX, et al. The expression of MYH9 in osteosarcoma and its effect on the migration and invasion abilities of tumor cell[J]. Asian Pac J Trop Med, 2016, 9(6): 597-600. doi: 10.1016/j.apjtm.2016.04.011
    [19] Yu MX, Wang JH, Zhu ZJ, et al. Prognostic impact of MYH9 expression on patients with acute myeloid leukemia[J]. Oncotarget, 2017, 8(1): 156-63. doi: 10.18632/oncotarget.10613
    [20] Schramek D, Sendoel A, Segal JP, et al. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas[J]. Science, 2014, 343(6168): 309-13. doi: 10.1126/science.1248627
  • 加载中
图(5) / 表(1)
计量
  • 文章访问数:  204
  • HTML全文浏览量:  184
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-09-21
  • 网络出版日期:  2023-01-18
  • 刊出日期:  2023-01-20

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日